← Leaderboards
John T Belisle
Stellenbosch University
$22,161,703
Attributed
$28,393,985
Total exposure
15
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.9M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$94,904,381 · 15
FDA$986,474 · 1
By mechanism
U54$73,440,320 · 5
U01$10,143,979 · 2
R01$8,191,403 · 3
R33$1,352,747 · 1
U18$986,474 · 1
N01$979,767 · 1
Top collaborators
- Maria Cristina Vidal Pessolani6 shared
- Jayne Sutherland5 shared
- Gerhard Walzl5 shared
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionBasePathogenBacteriaMolecularLaboratoriesImmune ResponseBiologicalDiagnosisSamplingBiosignatureComplexInnovationEvaluationLeadStructureSymptomsPreventResponseAreaDiagnosticReportingDiagnostic TestsEarly Diagnosis
Grant awards (62)
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)$1,059,114
U01 · FY2025 · AI
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)$1,500,000
U01 · FY2024 · AI
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)$1,500,000
U01 · FY2023 · AI
Host Metabolic Biosignatures for the Diagnosis of Lyme Disease$751,395
R01 · FY2023 · AI · contact PI
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy$564,477
R01 · FY2023 · AI · contact PI
Host Metabolic Biosignatures for the Diagnosis of Lyme Disease$752,280
R01 · FY2022 · AI · contact PI
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy$564,477
R01 · FY2022 · AI · contact PI
Host Metabolic Biosignatures for the Diagnosis of Lyme Disease$438,713
R01 · FY2022 · AI · contact PI
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy$177,928
R01 · FY2022 · AI · contact PI
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)$1,500,000
U01 · FY2021 · AI
Host Metabolic Biosignatures for the Diagnosis of Lyme Disease$753,386
R01 · FY2021 · AI · contact PI
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy$564,477
R01 · FY2021 · AI · contact PI
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)$1,500,000
U01 · FY2020 · AI
Host Metabolic Biosignatures for the Diagnosis of Lyme Disease$754,271
R01 · FY2020 · AI · contact PI
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy$564,477
R01 · FY2020 · AI · contact PI
Host Metabolic Biosignatures for the Diagnosis of Lyme Disease$781,156
R01 · FY2019 · AI · contact PI
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy$616,577
R01 · FY2019 · AI · contact PI
Biology and Biosignatures of Anti-Tuberculosis Treatment Response$590,863
U01 · FY2019 · AI · contact PI
Biology and Biosignatures of Anti-Tuberculosis Treatment Response$628,257
U01 · FY2018 · AI · contact PI
Biology and Biosignatures of Anti-Tuberculosis Treatment Response$585,300
U01 · FY2017 · AI · contact PI
Biology and Biosignatures of Anti-Tuberculosis Treatment Response$619,889
U01 · FY2016 · AI · contact PI
Metabolic biomarkers and biosignatures for improved diagnosis of Lyme disease$444,174
R33 · FY2016 · AI · contact PI
Biology and Biosignatures of Anti-Tuberculosis Treatment Response$660,556
U01 · FY2015 · AI · contact PI
Metabolic biomarkers and biosignatures for improved diagnosis of Lyme disease$453,098
R33 · FY2015 · AI · contact PI
Metabolic biomarkers and biosignatures for improved diagnosis of Lyme disease$455,475
R33 · FY2014 · AI · contact PI
Rocky Mountain Regional Center of Excellence or Biodefense and Emerging Infectiou$6,477,538
U54 · FY2013 · AI · contact PI
Administrative Core$514,663
U54 · FY2013 · AI · contact PI
Immunoproteome of F. tularensis$226,835
U54 · FY2013 · AI · contact PI
Metabolic biomarkers and biosignatures for improved diagnosis of Lyme disease$204,238
R21 · FY2013 · AI · contact PI
Rocky Mountain Regional Center of Excellence or Biodefense and Emerging Infectiou$7,102,851
U54 · FY2012 · AI · contact PI
Administrative Core$600,142
U54 · FY2012 · AI · contact PI
Immunoproteome of F. tularensis$499,715
U54 · FY2012 · AI · contact PI
Metabolic biomarkers and biosignatures for improved diagnosis of Lyme disease$216,156
R21 · FY2012 · AI · contact PI
Regulation of lipid biosynthesis in Mycobacterium tuberculosis$185,667
R21 · FY2012 · AI · contact PI
7th International Conference on Tularemia 2012$5,000
R13 · FY2012 · AI · contact PI
Rocky Mountain Regional Center of Excellence or Biodefense and Emerging Infectiou$7,054,719
U54 · FY2011 · AI · contact PI
Administrative Core$504,621
U54 · FY2011 · AI · contact PI
Small molecule biomarkers for tuberculosis treatment, relapse, and cure$493,237
U18 · FY2011 · FD · contact PI
Immunoproteome of F. tularensis$219,788
U54 · FY2011 · AI · contact PI
Regulation of lipid biosynthesis in Mycobacterium tuberculosis$185,104
R21 · FY2011 · AI · contact PI
Rocky Mountain Regional Center of Excellence or Biodefense and Emerging Infectiou$7,842,322
U54 · FY2010 · AI · contact PI
Administrative Core$562,089
U54 · FY2010 · AI · contact PI
Small molecule biomarkers for tuberculosis treatment, relapse, and cure$493,237
U18 · FY2010 · FD · contact PI
Immunoproteome of F. tularensis$248,490
U54 · FY2010 · AI · contact PI
Rocky Mountain Regional Center of Excellence or Biodefense and Emerging Infectiou$7,473,569
U54 · FY2009 · AI · contact PI
Rocky Mountain Regional Center of Excellence or Biodefense and Emerging Infectiou$1,710,939
U54 · FY2009 · AI · contact PI
Administrative Core$596,053
U54 · FY2009 · AI · contact PI
Immunoproteome of F. tularensis$214,936
U54 · FY2009 · AI · contact PI
Region VIII Research Center for Excellence for Biodefen*$10,030,594
U54 · FY2008 · AI · contact PI
Administrative Core$552,353
U54 · FY2008 · AI · contact PI
The Immunoproteome of Francisella Tularensis$315,440
U54 · FY2008 · AI · contact PI
Region VIII Research Center for Excellence for Biodefen*$9,869,569
U54 · FY2007 · AI · contact PI
The Immunoproteome of Francisella Tularensis$358,174
U54 · FY2007 · AI · contact PI
Region VIII Research Center for Excellence for Biodefen*$9,934,769
U54 · FY2006 · AI · contact PI
The Immunoproteome of Francisella Tularensis$266,253
U54 · FY2006 · AI · contact PI
The Immunoproteome of Francisella Tularensis$263,898
U54 · FY2005 · AI
GLYCOPROTEINS OF MYCOBACTERIUM TUBERCULOSIS$237,107
R01 · FY2003 · AI
GLYCOPROTEINS OF MYCOBACTERIUM TUBERCULOSIS$230,201
R01 · FY2002 · AI
GLYCOPROTEINS OF MYCOBACTERIUM TUBERCULOSIS$223,494
R01 · FY2001 · AI
TUBERCULOSIS RESEARCH MATERIALS AND VACINE TESTING$839,767
N01 · FY2000 · AI
GLYCOPROTEINS OF MYCOBACTERIUM TUBERCULOSIS$216,987
R01 · FY2000 · AI
TUBERCULOSIS RESEARCH MATERIALS AND VACINE TESTING$140,000
N01 · FY2000 · AI